IDS (XPAR:MLIDS) Research & Development: € Mil (TTM As of Dec. 2025)

IDS XPAR:MLIDS 35 Research & Development is € Mil as of Dec. 2025. GuruFocus rates XPAR:MLIDS with a GF Score™ of 35/100. The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. IDS's Research & Development for the six months ended in Dec. 2025 was €0.00 Mil. IDS does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in Dec. 2025.

IDS (XPAR:MLIDS) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

IDS Research & Development Related Terms

IDS Research & Development Historical Data

* Premium members only.

The historical data trend for IDS's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IDS Research & Development Chart

IDS Annual Data

Trend

Dec23

Dec24

Dec25

Research & Development

0.00

IDS Semi-Annual Data
	Dec23	Dec24	Dec25
Research & Development	0.00	0.00	0.00

35GF Score

IDS XPAR:MLIDS

Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

IDS Research & Development Calculation

This is the expense the company spent on research and development.

Frequently Asked Questions Learn more about Research & Development →

What does a Research & Development of € Mil mean?

IDS (XPAR:MLIDS) has a Research & Development of € Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on IDS and its competitors.

Is IDS's Research & Development too high?

IDS's current Research & Development is € Mil. Overall, IDS has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.

How does IDS's Research & Development compare to UBER and SHOP?

IDS's Research & Development of € Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Research & Development for a Software company?

A good Research & Development depends on the Software industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Research & Development mean?

A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on IDS and its competitors. IDS's current Research & Development is € Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is IDS stock overvalued right now?

IDS (XPAR:MLIDS) has a current Research & Development of € Mil. The current Research & Development is € Mil. IDS's overall GF Score™ is 35/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Research & Development calculated?

Research & Development is calculated from a company's financial statements. For IDS (XPAR:MLIDS), the current Research & Development is € Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.